Trials / Conditions / Non-Small Cell Squamous Lung Cancer
Non-Small Cell Squamous Lung Cancer
5 registered clinical trials studyying Non-Small Cell Squamous Lung Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With So NCT06051695 | A2 Biotherapeutics Inc. | Phase 1 / Phase 2 |
| Recruiting | A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers NCT05873686 | Nuvectis Pharma, Inc. | Phase 1 |
| Active Not Recruiting | A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors NCT05736731 | A2 Biotherapeutics Inc. | Phase 1 / Phase 2 |
| Unknown | Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases NCT05207904 | Sun Yat-sen University | Phase 2 |
| Unknown | Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer NCT06207292 | Radiotherapy Oncology Centre "Santa Maria" Hospital | N/A |